5 Followers USX:NVTA - Invitae Corp (USD 17.58) Invitae Corporation
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 17.58    +0.130 (+0.74%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

2 Jun 2020


Overview

2 Jun 2020

Day Change: 0.130 (0.74%)

52 Wk Range: 7.415 - 28.75

Day's Range: 17.08 - 17.865

Last Volume: 1,492,004

Current Yield: 0%

Projected Yield: 0%

Open: USD 17.63

2 Jun 2020

Metric NVTA S.Median
Beta 1.74 0.45
VaR 47.14 55.02
E.Shortfall 72.37 89.56
Liquidity 2.49M 2,718.04

Fundamental

2 Jun 2020

PE:

Market Cap: 5B

Price Over Book: 12.491

Price Over Sales: NA

Return On Assets:

Return On Equity:

Current Ratio: 7.377

General

CEO: Dr. Sean E. George

IPO: 2015-02-12

Headquarters: US

Employees: 1,500

Sector: Health Technology

Industry: Medical Specialties

Useful Links
Homepage

Description

Invitae Corporation, a genetic information company, processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients in the United States, Canada, and internationally. Its tests include genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders, and other hereditary conditions; and screening and testing services in reproductive health, including preimplantation and carrier screening for inherited disorders, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company also operates AltaVoice, a platform for collecting, curating, coordinating, and delivering data from patients and clinicians; and CancerGene Connect, an end-to-end platform for collecting and managing genetic family histories to deliver personalized genetic risk information. It serves patients, healthcare providers, and biopharma and advocacy partners. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.